Treatment modalities for narcolepsy

@article{Fry1998TreatmentMF,
  title={Treatment modalities for narcolepsy},
  author={June M. Fry},
  journal={Neurology},
  year={1998},
  volume={50},
  pages={S43 - S48}
}
  • J. Fry
  • Published 1998
  • Psychology, Medicine
  • Neurology
Narcolepsy, a lifelong disorder, requires long-term management of symptoms. Interventions may be nonpharmacologic, such as lifestyle changes, and pharmacologic for relief of daytime sleepiness. Pharmacologic treatment of narcolepsy has depended on the use of CNS stimulants to increase wakefulness, vigilance, and performance. The medications considered effective in the treatment of narcolepsy include dextroamphetamine, pemoline, methylphenidate, methamphetamine, and modafinil; only… Expand
Management of Narcolepsy
TLDR
Modafinil provides a useful alternative to traditional stimulants for the treatment of excessive daytime sleepiness associated with narcolepsy and shows long term efficacy without development of tolerance. Expand
Treatment of Hypersomnia
Central nervous system (CNS) hypersomnia disorders such as narcolepsy and idiopathic hypersomnia significantly impair quality of life and lead to safety risks in driving and occupational abilities.Expand
Narcolepsy in Children
TLDR
The current evidence supports the hypothesis that transmission of narcolepsy is multifactorial, with at least two genes, one of which is non-HLA related. Expand
Featured CME Topic: Narcolepsy Narcolepsy
Narcolepsy is a severely debilitating neurologic disease that is not as rare as many believe, affecting an estimated 140,000 Americans. Despite the sometimes debilitating nature of narcolepsyExpand
Chapter 13 Narcolepsy
Publisher Summary This chapter discusses Narcolepsy. The term narcolepsy was first coined by Gelineau in 1880 with the complete description of a patient with excessive daytime sleepiness (EDS), sleepExpand
Narcolepsy in the Older Adult
TLDR
The discovery that narcolepsy/cataplexy results from the absence of neuroexcitatory properties of the hypothalamic hypocretin-peptidergic system will significantly advance understanding and treatment of the symptom complex in the future. Expand
Narcolepsia en niños
Summary. Introduction. Narcolepsy is a neurological disorder characterized by excessive somnolence during the daytime, with recurrent, irresistible episodes of sleepiness. The complete forms areExpand
Pharmacological management of narcolepsy
TLDR
This review addresses the state-of-the-art knowledge about the pharmacological treatment of narcolepsy along with the personal view of the authors. Expand
Pharmacotherapy for excessive daytime sleepiness.
TLDR
Until adequately powered randomised-controlled trials confirm long-term efficacy and safety, the recommendation of wakefulness promoters in healthy adults cannot be justified. Expand
Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG
TLDR
These findings demonstrate that the alertness-promoting effects of modafinil and d-amphetamine involve distinct EEG activities and do not reside on the same vigilance regulatory processes. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 28 REFERENCES
Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy
  • Fry
  • Psychology, Medicine
  • Annals of neurology
  • 1998
TLDR
Modafinil demonstrated an excellent safety profile for up to 40 weeks of open‐label treatment and efficacy was maintained, suggesting that tolerance will not develop with long‐term use. Expand
Treatment of narcolepsy with methamphetamine.
TLDR
It is concluded that methamphetamine caused a dose-dependent decrease in daytime sleep tendency and improvement in performance in both narcoleptics and controls. Expand
NATURAL HISTORY, SYMPTOMS AND TREATMENT OF THE NARCOLEPTIC SYNDROME
TLDR
This study describes the clinical features, natural history and treatment of 100 patients with narcolepsy, with a minority of patients having muscle aches and jerks before sleep, double vision or loss of focus during cataplexy, went sleep‐walking by day, and had daytime hallucinations. Expand
Differential effects of a new central adrenergic agonist--modafinil--and D-amphetamine on sleep and early morning behaviour in young healthy volunteers.
Modafinil (CRL 40476) is a recently developed central alpha adrenergic agonist with vigilance-promoting properties. In a double-blind, placebo-controlled sleep laboratory study, its single-doseExpand
Modafinil in diurnal sleepiness. A study of 123 patients.
TLDR
The efficacy of modafinil, a psychostimulant drug acting on postsynaptic alpha-1 adrenergic receptors, as a treatment for excessive daytime sleepiness was studied in 123 patients and the incidence of side effects was rather low. Expand
Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil
TLDR
Modafinil, a putative central alpha 1 adrenergic agonist, was tested in idiopathic hypersomnia and narcolepsy and produces, in most cases, no peripheric sides effects, does not disturb night sleep and is never responsible of tolerance of drug dependence. Expand
Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat
TLDR
The results suggest that the arousal effect of modafinil does not depend on the availability of the endogenous catecholamines but results from an enhancement of alpha 1- and beta-receptor activity and that the waking and behavioral effects of amphetamine may be mainly due to an increase in dopamine release. Expand
Modafinil binds to the dopamine uptake carrier site with low affinity.
TLDR
The results suggest a nonadrenergic mode of action in modafinil, and experiments in narcoleptic canines have shown that the compound does not modify canine cataplexy even at doses promoting alertness. Expand
Maintenance of wakefulness test and multiple sleep latency test. Measurement of different abilities in patients with sleep disorders.
TLDR
The data demonstrate that patients with diagnosable disorders of excessive somnolence may be discordant on the two tests and that the MWT may be a useful adjuvant daytime test in many clinical situations. Expand
A new method for measuring daytime sleepiness: the Epworth sleepiness scale.
The development and use of a new scale, the Epworth sleepiness scale (ESS), is described. This is a simple, self-administered questionnaire which is shown to provide a measurement of the subject'sExpand
...
1
2
3
...